| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 12, 2024 | Sale | $67.77 | 1,148 | 77,796 | 92,453 | Feb 13, 2024, 05:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 29, 2024 | Sale | $64.14 | 906 | 58,109 | 93,601 | Jan 31, 2024, 04:36 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 22, 2024 | Sale | $65.00 | 3,413 | 221,831 | 94,507 | Jan 23, 2024, 06:15 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 16, 2024 | Sale | $66.81 | 2,235 | 149,317 | 97,920 | Jan 17, 2024, 04:37 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Dec 01, 2023 | Option Exercise | $15.09 | 110,000 | 1,659,900 | 186,407 | Dec 05, 2023, 07:29 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Dec 01, 2023 | Sale | $60.81 | 110,000 | 6,689,303 | 118,850 | Dec 05, 2023, 07:29 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | May 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 80,995 | May 04, 2023, 04:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | May 03, 2023 | Sale | $82.71 | 5,000 | 413,550 | 75,995 | May 04, 2023, 04:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Apr 03, 2023 | Sale | $74.05 | 5,000 | 370,250 | 75,995 | Apr 05, 2023, 04:50 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Apr 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 80,995 | Apr 05, 2023, 04:50 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Mar 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 80,995 | Mar 07, 2023, 04:53 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Mar 03, 2023 | Sale | $63.84 | 5,000 | 319,200 | 75,995 | Mar 07, 2023, 04:53 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 21, 2023 | Option Exercise | $58.50 | 1,041 | 60,899 | 75,995 | Feb 22, 2023, 06:36 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 10, 2023 | Option Exercise | $51.21 | 782 | 40,046 | 67,150 | Feb 14, 2023, 05:03 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 03, 2023 | Sale | $55.85 | 5,000 | 279,250 | 67,932 | Feb 06, 2023, 05:35 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 72,932 | Feb 06, 2023, 05:35 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 27, 2023 | Option Exercise | $52.77 | 551 | 29,076 | 67,932 | Jan 30, 2023, 05:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 20, 2023 | Option Exercise | $52.05 | 1,912 | 99,520 | 68,483 | Jan 24, 2023, 05:32 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 03, 2023 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Jan 05, 2023, 08:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 03, 2023 | Sale | $50.70 | 5,000 | 253,500 | 42,907 | Jan 05, 2023, 08:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Dec 05, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Dec 07, 2022, 08:30 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Dec 05, 2022 | Sale | $50.38 | 5,000 | 251,900 | 42,907 | Dec 07, 2022, 08:30 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Nov 03, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Nov 07, 2022, 04:19 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Nov 03, 2022 | Sale | $58.54 | 5,000 | 292,700 | 42,907 | Nov 07, 2022, 04:19 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Oct 03, 2022 | Sale | $66.69 | 5,000 | 333,450 | 42,907 | Oct 05, 2022, 05:12 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Oct 03, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Oct 05, 2022, 05:12 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Sep 06, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Sep 07, 2022, 04:37 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Sep 06, 2022 | Sale | $60.38 | 5,000 | 301,900 | 42,907 | Sep 07, 2022, 04:37 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 15, 2022 | Option Exercise | $15.09 | 12,500 | 188,625 | 55,407 | Aug 16, 2022, 05:04 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 15, 2022 | Sale | $69.00 | 12,500 | 862,500 | 42,907 | Aug 16, 2022, 05:04 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 11, 2022 | Sale | $67.00 | 12,500 | 837,500 | 42,907 | Aug 12, 2022, 05:01 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 11, 2022 | Option Exercise | $15.09 | 12,500 | 188,625 | 55,407 | Aug 12, 2022, 05:01 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 08, 2022 | Option Exercise | $15.09 | 12,500 | 188,625 | 55,407 | Aug 09, 2022, 05:22 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 08, 2022 | Sale | $65.00 | 12,500 | 812,500 | 42,907 | Aug 09, 2022, 05:22 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 03, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 42,907 | Aug 04, 2022, 06:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Aug 03, 2022 | Sale | $56.43 | 5,000 | 282,150 | 37,907 | Aug 04, 2022, 06:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jul 11, 2022 | Option Exercise | $15.09 | 5,000 | 75,450 | 47,907 | Jul 12, 2022, 05:55 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jul 11, 2022 | Sale | $48.42 | 5,000 | 242,100 | 42,907 | Jul 12, 2022, 05:55 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Jan 28, 2022 | Option Exercise | $38.59 | 800 | 30,872 | 44,908 | Feb 01, 2022, 06:01 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Townsend Adam J. | Chief Commercial Officer | Feb 10, 2021 | Option Exercise | $47.72 | 688 | 32,831 | 18,865 | Feb 11, 2021, 04:10 PM |
Menu